Goodrich Katherine bought TARS
December 15, 2025 · Form 4 insider transaction
Goodrich Katherine bought 2,233 shares of Tarsus Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 30 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,233
Price
N/A
Total value
N/A
InsiderGoodrich Katherine
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 15, 2025
Filing dateJanuary 14, 2026
Shares owned after2,233
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.